Our results from overexpressing FAST-1 in three different non-FRDA cell lines now demonstrate that FAST-1 can act in trans in a similar manner to the cis-acting FAST-1 overexpression that has previously been identified in FRDA fibroblasts. The gene discussed is FOXH1; the disease is Friedreich ataxia.